Published on:
Now, 98 per cent of people living with HIV in the UK are on effective treatment and 97 per cent cant pass the virus on.
Researchers and clinicians at Queen Mary University of London and Barts Health NHS Trust are at the forefront of leadership and research to develop innovative treatments, reduce health inequalities and fight stigma to support better health for all those living with HIV.
As former chairs of the British HIV Association (BHIVA) Queen MarysProfessor Chloe Orkin and Honorary Professor Jane Anderson have been integral in transforming the lives of people living with and affected by HIV.
Despite the vast progress in terms of HIV care and treatments, continued efforts are still needed to fight HIV stigma. For example, recent research from the National AIDS Trust suggests that only 16 per cent of people know that if someone is on effective treatment, they cant pass HIV on and can expect to live a long and healthy life.
In 2019, Chloe Orkin, Professor of HIV medicine at Queen Mary and Consultant Physician at Barts Health NHS Trust featured in the BBC documentary "HIV and Me," with former Wales rugby captain Gareth Thomas. As part of the programme, she helped him to tackle some of the stigmas, myths and misunderstandings surrounding the condition.
Consistent use of antiretroviral therapy (ART) by people living with HIV to maintain an undetectable viral load is a highly effective strategy to prevent the sexual transmission of HIV.
During her time as BHIVA chair, Professor Orkin played a significant role in the associations support for the Undetectable=Untransmittable (U=U) statement, which unambiguously states that a person on fully suppressive HIV treatment cannot transmit HIV. Under Professor Orkins leadership, BHIVA were early champions of the statement and supporting campaign, providing guidance and resources for health care professionals to ensure the U=U message is consistently integrated into clinical care.
Professor Jane Anderson now co-chairs Londons Fast Track Cities group who are working to get London to Zero by 2030: zero new HIV infections, zero preventable deaths, zero HIV associated stigma and best quality of life for people living with HIV before 2030. In October, Londons considerable progress towards this goal was internationally recognised at the Fast-Track Cities international conference where the capital received a HIV excellence award.
Professor Anderson has also recently worked as part of a group of global experts to develop an international consensuson the role of health systems in securing the wellbeing of people living with HIV for the long term.
Ethnic inequalities are commonly seen in many different areas of health, and they have also been reported in HIV Care within Europe and the US. In a study published earlier this year, a research team led by Dr Rageshri Dhairyawan, a Consultant in Sexual Health and HIV Medicine at Barts Health NHS Trust and an Honorary Senior Lecturer at Queen Mary, explored if similar inequalities existed in HIV treatment and care amongst heterosexual men and women living with HIV in the UK.
The researchers found that people from Black, Asian and minority ethnic (BAME) groups were more likely to be diagnosed late, experience viral rebound and spend less time engaged in care, compare to white groups.
Due to advances in HIV treatment and care, people with HIV are living longer. Increasing numbers of women living in the UK are reaching older age, and in 2018, almost 15,000 women attending HIV care were aged 45 years or over. Despite this, little is known about the social and mental health impacts of living with HIV for older women, especially those belonging to ethnic minority groups.
In a recent UK study, researchers explored the links between socioeconomic factors, mental health and ethnicity in women between 45-60 years old living with HIV in England. The findings show that older women with HIV experiencedhigh levels of poverty, psychological distress and social isolation, and that these socioeconomic and psychological impacts were especially prevalent among Black African women of this age. Despite being more likely to experience psychological distress, Black African women were less likely to have been diagnosed with depression likely due to possible inequity in access to mental health services.
This November, the National Institute for Health and Care Excellence (NICE) approved the first long-acting injectable treatment for HIV-1 infection.
The First Long-Acting Injectable Regimen (FLAIR) study, published in the NEJM and led by Professor Orkin, first showed that a monthly injection of the HIV drug combination (containing the drugs cabotegravir and rilpivirine) is as effective as the standard daily oral treatment for suppressing the HIV virus.
Until recently, approval of this treatment required an initial four-week period of oral therapy before the first injections, which is less convenient for patients and more complicated to implement in clinical practice. In October, Professor Orkin and colleagues published new results from the study showing that the safety and effectiveness of this injectable HIV drug treatment was similar with or without the initial lead-in period of oral therapy. As a result, the European regulatory agency (EMEA) has now updated its prescribing guidance for health care professionals to give people living with HIV the option to start with injections without an initial period of oral therapy.
In 2019, news of a second patient free of HIV following stem-cell therapy reignited the possibility of an HIV cure. The London-based patient had received a stem cell transplant that replaced their white blood cells with HIV-resistant versions and following this was able to stop taking ART.
Dr John Thornhill, Consultant Physician at Barts Health NHS Trust, was part of the team led by Professor Ravi Gupta tasked with looking for signs of the virus in the patient 30 months after stopping treatment. Together, they were able to confirm that there was no evidence that the virus had returned, hinting that the first case of this successful stem cell transplant decades earlier may not have just been a one-off.
In another study, Professor Sarah Fidler, Dr Thornhill and other colleagues tested analternative HIV cure strategy, kick and kill, which aims to deplete groups of HIV-infected cells, known as the HIV reservoir, that cannot be killed with current treatments and act as a barrier to a HIV cure. The researchers tested whether using drugs called histone deacetylase inhibitors alongside a therapeutic HIV vaccine, could make these cells easier to kill. Whilst the findings show that this approach was not any more effective at depleting the HIV reservoir than current ART therapy, the researchers suggest this type of approach could still hold promise and that further trials are required.
The Covid-19 pandemic laid bare some of the longstanding health inequalities that exist within our local East London community. Dr Vanessa Apea, a Consultant Physician in Sexual Health and HIV Medicine at Queen Mary has established a new research project, Amplifying Lives, to understand the lived experiences and needs of Black, Asian and Minority Ethnic Communities in East London.
As part of this project, Dr Apea will explore the journey to late diagnosis of HIV in women of Black African heritage. It is hoped this work will support the development of targeted interventions and pathways aimed at earlier diagnosis and improved outcomes in this group.
TheSexual Health and HIV All East Research (SHARE) Collaborative, a new HIV research centre, was established earlier this year to address health inequalities and improve quality of life for everyone affected by HIV. The centre, funded by Barts Charity, brings together expertise from Queen Mary University of London and Barts Health NHS Trust and aims tofind ways to prevent future HIV infections and trial innovative new treatments.
The dedicated centre is based in East London, where many minoritised communities have been disproportionately affected by HIV and poor sexual health, with some of the highest rates of HIV infection in England.
The SHARE team is working in partnership with local people to develop collective knowledge about HIV and sexual health. They hope this approach will provide rich understanding of the health needs of local people and help find ways towards health equity whilst ensuring no one is left behind.
Related news story: New HIV centre set up to tackle inequality and improve treatment
Link:
World Aids Day Improving the lives of everyone affected by HIV - QMUL
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
- Is Phenq Right For You? Review The Facts Before Making a ... - Vashon-Maury Island Beachcomber - November 27th, 2023
- Cavityn Reviews - Does It Work? Cheap Scam or Effective ... - The Daily World - November 25th, 2023
- Trend Hunting With Beautystreams At Cosmoprof Asia 2023 - BeautyMatter - November 25th, 2023
- FDA Considers First CRISPR Gene Editing Treatment That May ... - Slashdot - November 25th, 2023
- How Do Plants Determine Where the Light Is Coming From? - Lab Manager Magazine - November 25th, 2023
- Deaths From Coal Pollution Have Dropped, But Emissions May be ... - Slashdot - November 25th, 2023
- Stem cell-based therapies for stroke in newborns - Cochrane - November 23rd, 2023
- Dr Leslie on Outpatient CAR T-Cell Therapy Programs for ... - OncLive - November 23rd, 2023
- Human Milk-Based Therapy May Be Beneficial in Blood Cancers - Curetoday.com - November 23rd, 2023
- Oncological Horizons: The Synergy of Medical and Surgical ... - Cureus - November 23rd, 2023
- Human and environmental safety of carbon nanotubes across their ... - Nature.com - November 23rd, 2023
- Immix Biopharma to Host KOL Event to Discuss its BCMA-Targeted ... - BioSpace - November 23rd, 2023
- #HearTheMarsdenKids call on NHS London to reconsider cancer ... - Metro.co.uk - November 23rd, 2023
- Diagnosis and Management of Cardiovascular Risk in Patients with ... - Dove Medical Press - November 23rd, 2023
- BioLineRx Reports Third Quarter 2023 Financial Results and ... - PR Newswire - November 21st, 2023
- Why our Award Winners Beauty Box is the ultimate beauty gift (for ... - Yahoo Singapore News - November 21st, 2023
- SightCare Reviews - Is Official Website for Sight Care Legit to Try or ... - Vashon-Maury Island Beachcomber - November 21st, 2023
- Legend Biotech Reports Third Quarter 2023 Results and Recent ... - StreetInsider.com - November 21st, 2023
- Lorenzo's Oil: Can It Really Treat ALD? - Verywell Health - November 19th, 2023
- Doctor Says Living To 120 By End Of Decade Is Possible What's the Secret? - Benzinga - November 19th, 2023
- The week in pharma: action, reaction and insight week to ... - The Pharma Letter - November 19th, 2023
- Race Cannot Be Used To Predict Heart Disease, Scientists Say ... - Slashdot - November 19th, 2023
- SpaceX's Starship Reaches Outer Space Before Intentional ... - Slashdot - November 19th, 2023
- Mesenchymal Stem Cells Market is projected to reach USD 3,319 million by 2030 according to a new research r... - WhaTech Technology and Markets News - November 17th, 2023
- LMRUK: Protecting the next generation through cord blood - Charity Today News - November 17th, 2023
- Anti-aging molecule discovered that extends lifespan - Earth.com - November 17th, 2023
- Montana State researcher envisions living building materials that ... - Montana State University - November 17th, 2023
- OxyHelp Explores the Benefits of Hyperbaric Oxygen Therapy for ... - StreetInsider.com - November 15th, 2023
- Health benefits of bone marrow - Pakistan Observer - November 15th, 2023
- Evolving the standard of care: What is next for functional ... - NeuroNews International - November 15th, 2023
- Affimed Reports Third Quarter 2023 Financial Results and ... - BioSpace - November 15th, 2023
- Meet the World's First Whole-Eye Transplant Recipient - TIME - November 15th, 2023
- Calidi Biotherapeutics Reports Third Quarter 2023 Operating and ... - Business Wire - November 15th, 2023
- 10 Asia-Pacific biotech companies leading innovation in the region - Labiotech.eu - November 15th, 2023
- Fitspresso Reviews (November Update) Natural Ingredients That ... - Bainbridge Island Review - November 15th, 2023
- 2seventy bio Reports Third Quarter Financial Results and Recent ... - Business Wire - November 15th, 2023
- Japan To Create $6.6 Billion Fund To Develop Outer Space Industry ... - Slashdot - November 15th, 2023
- Be The Match, Healthcare Marketing Impact Awards 2023 - Ad Age - November 13th, 2023
- Medicare coverage saves lives. Enrolling shouldn't be this ... - Kevin MD - November 13th, 2023
- Future Ocean Foods: 36 Global Alt-Seafood Startups Form Association To Tackle Overfishing, Microplastics & More - Green Queen Media - November 13th, 2023
- Orchard Therapeutics Reports Third Quarter 2023 Financial Results ... - StreetInsider.com - November 13th, 2023
- Celebrity doctor reveals Hollywoods hidden trend of stem cell antiaging therapies - Longevity.Technology - November 11th, 2023
- Amazon Expands Healthcare Push With One Medical Benefits For ... - Slashdot - November 11th, 2023
- Bene Meat Technologies becomes the first to receive EU approval ... - Pet Food Processing - November 11th, 2023
- FDA Grants Orphan Drug Designation to MAIA Biotechnology for THIO as a Treatment for Glioblastoma - Yahoo Finance - November 11th, 2023
- MaaT Pharma Provides Third Quarter 2023 Business Update and ... - Business Wire - November 11th, 2023
- IN8bio Reports Third Quarter 2023 Financial Results and Provides ... - GlobeNewswire - November 11th, 2023
- Fast Lean Pro Reviews - Overpriced or Optimal Ingredients That ... - Journal of the San Juan Islands - November 11th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - GlobeNewswire - November 11th, 2023
- Worlds first whole-eye and partial face transplant gives Arkansas man new hope - CNN - November 9th, 2023
- Glowing Fingertips And Green Eyes: First-of-Its-Kind Monkey ... - ScienceAlert - November 9th, 2023
- 10 Natural Body Scrubs That Exfoliate And Invigorate My Skin - PINKVILLA - November 9th, 2023
- CRISPR Therapeutics Provides Business Update and Reports Third ... - StreetInsider.com - November 9th, 2023
- Fate Therapeutics Reports Third Quarter 2023 Financial Results and ... - StreetInsider.com - November 9th, 2023
Recent Comments